Ceftriaxone & Tazobactam 562.5mg Injection Exporter from India to USA, UK, Australia, Singapore, Thailand, and Jamaica | Premium Antibiotic Combination Supplier | Ernest Impex Global Medicine Logistics

Extensive Product Profile: Understanding Ceftriaxone & Tazobactam for Injection 562.5 mg

Ceftriaxone & Tazobactam for Injection 562.5 mg is a powerful combination antibiotic used in clinical settings to treat moderate to severe bacterial infections. It combines Ceftriaxone Sodium, a broad-spectrum, third-generation cephalosporin, with Tazobactam Sodium, a beta-lactamase inhibitor that protects the antibiotic from degradation by resistant bacteria.

1. Clinical Indications & Usage

This synergistic formulation is indicated for the treatment of infections caused by susceptible organisms, including:

Lower Respiratory Tract Infections: Such as pneumonia and severe bronchitis.

Urinary Tract Infections (UTIs): Including complicated infections and pyelonephritis.

Intra-abdominal Infections: Management of peritonitis and biliary tract infections.

Skin and Soft Tissue Infections: Treatment of complicated skin and structure infections.

Septicemia: Management of serious systemic bacterial infections.

Surgical Prophylaxis: Administered to prevent infections associated with invasive surgical procedures.

2. Mechanism of Action

The combination utilizes a dual-pathway approach to combat infection:

Ceftriaxone: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to bacterial cell death (bactericidal activity).

Tazobactam: Acts as a potent beta-lactamase inhibitor. By irreversibly binding to beta-lactamase enzymes, it prevents the breakdown of ceftriaxone, thereby extending its spectrum of activity against many resistant strains of bacteria.

3. Administration and Dosing

Route: Administered via intravenous (IV) infusion or deep intramuscular (IM) injection.

Preparation: The sterile powder must be reconstituted with compatible diluents (e.g., Sterile Water for Injection, 0.9% Sodium Chloride) immediately before use.

Dosing: Dosage is strictly determined by a physician based on the infection's severity, the patient's renal/hepatic function, and age.

⚠️ Safety, Side Effects, and Monitoring

Hypersensitivity: Contraindicated in patients with a history of severe allergic reactions (anaphylaxis) to cephalosporins, penicillins, or beta-lactamase inhibitors.

Precautions: Avoid mixing with calcium-containing solutions, especially in neonates, to prevent the formation of precipitates.

Common Side Effects: Local injection site reactions (pain, phlebitis), gastrointestinal issues (diarrhea, nausea, vomiting), and skin rash.

Monitoring: Patients should be monitored for signs of C. difficile-associated diarrhea or systemic allergic reactions throughout the course of treatment.

📦 Storage and Handling

Storage: Keep the un-reconstituted powder in its original packaging at controlled room temperature (20°C to 25°C), protected from light and excessive moisture.

Stability: Once reconstituted, the solution should be used promptly in accordance with established clinical sterile protocols.

PRESCRIPTION MEDICINE IS : YES

Clinical Disclaimer: This profile is compiled for medical professional information and clinical research. Ceftriaxone & Tazobactam 562.5 mg is a prescription-only medication and must be administered strictly under the supervision of a licensed physician or medical facility. The use of this medication during pregnancy should be considered only if the potential benefit justifies the risk.

📞 Contact Ernest Impex — Pharmaceutical Exporter from India

[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]

🌐 Websites:

www.ernestimpex.com

www.oncologymedicinesupplier.com

www.ernestpharmaceuticals.com

www.ernestvision.com

📧 Email: exports@ernestpharmaceuticals.com

📦 Business Type: Exporter | Supplier | Distributor

📲 WhatsApp: +91 93599 02383

📲 WhatsApp Link: https://wa.me/919359902383